Novartis’s Iptacopan (Fabhalta) Receives Marketing Approval in China for PNH Treatment
Swiss pharmaceutical giant Novartis (NYSE: NVS) has received marketing approval from China for its iptacopan...
Swiss pharmaceutical giant Novartis (NYSE: NVS) has received marketing approval from China for its iptacopan...
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760) has announced its financial results for 2023,...
Shanghai-based United Imaging Healthcare (UIH, SHA: 688271) has reported impressive financial results for the year...
AbbVie (NYSE: ABBV) has announced positive results from a head-to-head Phase IIIb/IV clinical trial comparing...
Yang Xiaoming, previously the chief engineer and chief scientist of China National Pharmaceutical Group Corporation...
China-based Neusoft Medical Systems Co., Ltd has entered into a strategic partnership with West China...
Sino-US biotechnology company AbelZeta Pharma Inc., operating in Rockville, Maryland, and Shanghai, China, has received...
Japanese pharmaceutical giant Takeda (NYSE: TAK) has officially withdrawn its membership from the Biotechnology Innovation...
UK-based pharmaceutical giant AstraZeneca (AZ; NASDAQ: AZN) has released an impressive set of financial results...
China-based MicroPort Scientific Corp (HKG: 0853), a leading medical device company, announced that its spin-off,...
Beijing-based Allgens Medical Technology Co., Ltd (SHA: 688613), specializing in regenerative medicine materials and implantable...
Wuhan Bio-Raid Biotechnology Co., Ltd, a leading developer of chimeric antigen receptor (CAR)-T cell therapies...
China-based Clover Biopharmaceuticals, Ltd (HKG: 2197) has announced its financial results for 2023, recording its...
China-based JW Therapeutics (HKG: 2126) has announced its financial results for 2023, with revenues reaching...
Merck, Sharp & Dohme (MSD; NYSE: MRK) has released its financial report for the first...
China-based biopharmaceutical company Hua Medicine (HKG: 2552) has released its financial report for 2023, with...
Yantai Dongcheng Pharmaceutical Group Co., Ltd (SHE: 002675) has announced that its controlling subsidiary, Yantai...
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced that the National Medical Products Administration...
Chia Tai Tianqing has announced the successful completion of a Phase I clinical study for...
Shanghai Henlius Biotech Inc. (HKG: 2696) has achieved a significant milestone with the US Food...